Search Result "CBP inhibitors."
Recent Advances in the Development of CBP/p300 Bromodomain Inhibitors
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 33 Year: 2020 Page: 5583-5598
Author(s): Ying Xiong,Mingming Zhang,Yingxia Li
E7386 is not a Specific CBP/β-Catenin Antagonist
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-10
Author(s):
Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 18 Issue: 4 Year: 2018 Page: 296-309
Author(s): Jinlian Wei,Yingrui Yang,Mengchen Lu,Yonghua Lei,Lili Xu,Zhengyu Jiang,Xiaoli Xu,Xiaoke Guo,Xiaojin Zhang,Haopeng Sun,Qidong You
CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 6 Year: 2015 Page: 519-532
Author(s): Zanxian Xia,Mingquan Guo,Han Liu,Luwei Jiang,Qiaoxia Li,Jian Peng,Jia-Da Li,Baoen Shan,Pinghui Feng,Hong Ma
Hypoxia Selects for a Quiescent, CML Stem/Leukemia Initiating- Like Population Dependent on CBP/Catenin Transcription
Journal: Current Molecular Pharmacology
Volume: 6 Issue: 3 Year: 2013 Page: 204-210
Author(s): Aiko Kida,Michael Kahn
Curcumin is an Inhibitor of p300 Histone Acetylatransferase
Journal: Medicinal Chemistry
Volume: 2 Issue: 2 Year: 2006 Page: 169-174
Author(s): Len Neckers, Jane Trepel, Sunmin Lee, Eun-Joo Chung, Min-Jung Lee, Yun-Jin Jung, Monica G. Marcu
Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5051-5064
Author(s): Luis M. Valor, Jose Viosca, Jose P. Lopez-Atalaya, Angel Barco
Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists
Journal: Current Molecular Pharmacology
Volume: 11 Issue: 2 Year: 2018 Page: 113-121
Author(s): Yi Zhao,Kaijin Wu,Yongfeng Wu,Elizabeth Melendez,Goar Smbatyan,David Massiello,Michael Kahn
Exploring the Role of Asp1116 in Selective Drug Targeting of CREBcAMP- Responsive Element-binding Protein Implicated in Prostate Cancer
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 23 Issue: 3 Year: 2020 Page: 178-184
Author(s): Oluwayimika E. Akinsiku,Opeyemi S. Soremekun,Fisayo A. Olotu,Mahmoud E.S. Soliman
The Gamma Catenin/CBP Complex Maintains Survivin Transcription in β-catenin Deficient/Depleted Cancer Cells
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 2 Year: 2011 Page: 213-225
Author(s): Y.-M. Kim, H. Ma, V. G. Oehler, E. J. Gang, C. Nguyen, D. Masiello, H. Liu, Y. Zhao, J. Radich, M. Kahn